DAFTAR PUSTAKA
1. Atlas IDFD. International Diabetes Federation. 9 ed. Vol. 266, The Lancet.
1955. 134–137 hal.
2. Abdul M, Khan B, Hashim MJ, King JK, Govender RD, Mustafa H, et al.
Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10:107–11.
3. Kementrian Kesehatan RI. Tetap produktif, cegah dan atasi Diabetes Mellitus. InfoDATIN Kemenkes. 2020.
4. Sarihati IGAD, Karimah HN, Habibah N. Gambaran kadar HbA1C pada Pasien diabetes mellitus tipe 2 di RSUD Wangaya. Meditory J Med Lab.
2019;6(2):88–98.
5. Soelistijo SA. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia. Glob Initiat Asthma [Internet]. 2020;46. Tersedia pada: www.ginasthma.org.
6. Wulandari IAT, Herawati S, Wande IN. Gambaran kadar HbA1c pada Pasien Diabetes Melitus Tipe II di RSUP Sanglah periode Juli - Desember 2017. J Med Udayana. 2020;9(1):71–5.
7. Sherwood L. Introduction to human physiology. Ed 8. China: United States of America Brooks/Cole. 2013
8. Yuan Q, Pan A, Fu Y, Dai Y. Anatomy and Physiology of The Pancreas [Internet]. Integrative Pancreatic Intervention Therapy: A Holistic Approach. INC; 2020. 3–21 hal. Tersedia pada:
http://dx.doi.org/10.1016/B978-0-12-819402-7.00001-2
9. Malone JI, Hansen BC. Does obesity cause type 2 diabetes mellitus (T2DM)?
Or is it the opposite? Pediatr Diabetes. 2019;20(1):5–9.
10. Artasensi A, Pedretti A, Vistoli G, Fumagalli L. Type 2 diabetes mellitus: A review of multi-target drugs. 2020;1–20. Tersedia pada:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221535/
11. Musaiger AO. Diabetes Mellitus in Bahrain: An Overview. Diabet Med.
1992;9(6):574–8.
12. Javeed N, Matveyenko A V. Circadian Etiology of Type 2 Diabetes Mellitus.
Physiology [Internet]. 1 Maret 2018;33(2):138–50. Tersedia pada:
https://www.physiology.org/doi/10.1152/physiol.00003.2018
13. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci.
2020;21(17):1–34.
14. Sangwung P, Petersen KF, Shulman GI, Knowles JW. Potential role of alterations in mitochondrial function in the pathogenesis of insulin resistance and type 2 diabetes. Endocrinol (United States). 2021;161(4):1–10.
15. Hale DE, Weinzimer SA. Type 2 Diabetes Mellitus in Children and Adolescents. Pediatr Endocrinol Requisites. 2004;19–35.
16. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014;37(SUPPL.1):120–43.
17. Raveendran A V., Chacko EC, Pappachan JM. Non-pharmacological treatment options in the management of diabetes mellitus. Eur Endocrinol.
2020;14(2):31–9.
18. Petroni ML, Brodosi L, Marchignoli F, Sasdelli AS, Caraceni P, Marchesini G, et al. Nutrition in Patient with Type 2 Diabetes: Present Knowledge and Remaining Challenges. Nutrients 2021;1–23.
19. Sigal RJ, Armstrong MJ, Colby P, Kenny GP, Plotnikoff RC, Reichert SM, et al. Physical Activity and Diabetes. Can J Diabetes [Internet].
2013;37(SUPPL.1):S40–4. Tersedia pada:
http://dx.doi.org/10.1016/j.jcjd.2013.01.018
20. Care D, Suppl SS. Obesity management for the treatment of type 2 diabetes:
Standards of medical care in diabetes-2021. Diabetes Care.
2021;44(January):S100–10.
21. Dunstan DW, Daly RM, Owen N, Jolley D, De Courten M, Shaw J, et al.
High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care. 2002;25(10):1729–36.
22. Moghaddasi Y, Ghazalian F, Abediankenari S, Ebrahim K, Abednatanzi H.
Effect of aerobic and resistance training on gdf-15 levels in patients with
type 1 diabetes. J Maz Univ Med Sci. 2020;30(186):123–32.
23. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD.
Physical activity/exercise and type 2 diabetes: A consensus statement from the American Diabetes Association. Diabetes Care. 2006;29(6):1433–8.
24. Kolb L. An Effective Model of Diabetes Care and Education: The ADCES7 Self-Care BehaviorsTM. Sci Diabetes Self-Management Care.
2021;47(1):30–53.
25. Vítovec J, Špinar J, Špinarová L. Diabetes Mellitus and Cardiovascular disease. Kardiol Rev. 2018;20(2):118–22.
26. Perkeni. Terapi Insulin pada Pasien Diabetes Melitus. Angewandte Chemie International Edition, 6(11), 951–952. 2019. 106–111 hal.
27. Care D, Suppl SS. Glycemic targets: standards of medical care in Diabetes 2018. Diabetes Care. 2018;41(January):S55–64.
28. Nelson AJ, Rochelau SK, Nicholls SJ. Managing Dyslipidemia in Type 2 Diabetes. Endocrinol Metab Clin North Am [Internet]. 2018;47(1):153–73.
Tersedia pada: https://doi.org/10.1016/j.ecl.2017.10.004
29. Haile K, Timerga A. Dyslipidemia and its associated risk factors among adult type-2 diabetic patients at jimma university medical center, Jimma, Southwest Ethiopia. Diabetes, Metab Syndr Obes Targets Ther.
2020;13:4589–97.
30. P2PTM. Berapa nilai LDL Anda ? [Internet]. Kemenkes RI. 2018. Tersedia pada: https://p2ptm.kemkes.go.id/preview/infografhic/berapa-nilai-ldl-anda 31. Triana V. Faktor yang berhubungan dengan pemberian Imunisasi Dasar
Lengkap pada bayi tahun 2015. J Kesehat Masy Andalas. 2017;10(2):123.
32. Delfina S, Carolita I, Habsah S, Ayatillahi S. Analisis Determinan Faktor Risiko Kejadian Diabetes Mellitus Tipe 2 pada Usia Produktif. J Kesehat Tambusai. 2021;2(4):141–51.
33. Kistianita AN, Yunus M, Gayatri RW. Analisis Faktor Risiko Diabetes Mellitus Tipe 2 Pada Usia Produktif Dengan Pendekatan WHO Stepwise Step 1 (Core/Inti) di Puskesmas Kendalkerep Kota Malang. Prev Indones J Public Heal. 2018;3(1):85.
34. Gunawan S, Rahmawati R. Hubungan Usia, Jenis Kelamin dan Hipertensi dengan Kejadian Diabetes Mellitus Tipe 2 di Puskesmas Tugu Kecamatan Cimanggis Kota Depok Tahun 2019. ARKESMAS (Arsip Kesehat Masyarakat). 2021;6(1):15–22.
35. Komariah K, Rahayu S. Hubungan Usia, Jenis Kelamin Dan Indeks Massa Tubuh dengan Kadar Gula Darah Puasa pada Pasien Diabetes Melitus Tipe 2 di Klinik Pratama Rawat Jalan Proklamasi, Depok, Jawa Barat. J Kesehat Kusuma Husada. 2020;(Dm):41–50.
36. Amelia R, Lelo A, Lindarto D, Mutiara E. Quality of life and glycemic profile of type 2 diabetes mellitus patients of Indonesian: A descriptive study. IOP Conf Ser Earth Environ Sci. 2018;125(1).
37. Betteng R. Analisis Faktor Resiko penyebab terjadinya Diabetes Melitus Tipe 2 pada Wanita Usia Produktif di Puskesmas Wawonasa. J e-Biomedik.
2014;2(2).
38. Amran P, Rahman R. Gambaran hasil pemeriksaan HbA1C pada Penderita Diabetes Melitus Tipe II di RSUD Labuang Baji Makassar. J Media Anal Kesehat. 2018;9(2):149–55.
39. Fadhila Akhsana NR, Aryani T, Widyantara AB. Literature Review:
Gambaran hasil pemeriksaan HbA1c, Glycated Albumin dan Rasio pemeriksaan Glycated Albumin: Hba1C pada Pasien Diabetes Melitus. Progr Stud Teknol Lab Medis Fak Ilmu Kesehat di Univ ’Aisyiyah Yogyakarta.
2021;10(November 2021):1–14.
40. Saputra MD, Muflihatin SK. Hubungan Stres dengan Terkendalinya Kadar Gula Darah pada Pasien DM Tipe II di Irna RSUD Abdul Wahab Sjahranie Samarinda Muhammad. Borneo Student Res. 2020;1(3):1672–8.
41. Kassaming K, Fadli F, Marzuki S. Relationship Between Self-Care Behavior and Diabetes Self-Management Education in Type 2 Diabetes Mellitus Patients. J Pendidik Keperawatan Indones. 2022;8(1):1–8.
42. Putri L. Gambaran Penggunaan Jenis Obat Antidiabetes dan Pengetahuan Pasien Diabetes Melitus Tipe 2 di Poliklinik Penyakit Dalam RSUD Arifin
Achmad Pekanbaru. 2013;1–9. Tersedia pada:
http://103.10.169.96/xmlui/handle/123456789/2206
43. Yulia D, Miro S, Kamil ZI. Gambaran Kadar Glukosa Darah Puasa dan D- dimer pada Pasien Diabetes Tipe 2 Terkontrol. J Ilmu Kesehat Indones.
2022;3(1):1–7.
44. Hermawati AH, Puspitasari E, Nurmala CL. Low Density Lipoprotein (LDL) in Type 2 Diabetes Mellitus. Med Lab Anal Sci J. 2019;1(1):25–9.
45. Huang X, Liu G, Guo J, Su ZQ. The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483–96.
46. Bonilha I, Hajduch E, Luchiari B, Nadruz W, Goff W Le, Sposito AC. The reciprocal relationship between LDL metabolism and type 2 diabetes mellitus. Metabolites. 2021;11(12).
47. Anggraini R. Korelasi Kadar Kolesterol dengan Kejadian Diabetes Mellitus Tipe 2 pada Laki-Laki. Med Heal Sci J. 2018;2(2):55–60.
48. Yulianti SR, Mukaddas A, Faustine I. Profil Pengobatan Pasien Diabetes Mellitus Tipe 2 di Instalasi Rawat Inap RSUD Undata Palu Tahun 2021. J Nat Sci. 2021;3(March):40–6.
49. Arini, Ni Made Alit. Dwipayana IMP. Hubungan Kadar HbA1c terhadap Terapi Obat Anti Diabetes Oral dan Kombinasi Obat Anti Diabetes Oral- Insulin pada Penderita DM Tipe 2 di Poliklinik Diabetes RSUP Sanglah Denpasar Tahun 2016. J Med Udayana [Internet]. 2020;9(9):94–8. Tersedia pada: https://ojs.unud.ac.id/index.php/eum/article/download/66590/37167/
50. Paczkowska A, Hoffmann K, Michalak M, Bryl W, Kopciuch D, Zaprutko T, et al. A comparison between the therapeutic effect of metformin alone versus a combination therapy with insulin in uncontrolled, non-adherence patients with type 2 diabetes: Six months follow-up. Diabetes, Metab Syndr Obes. 2021;14(May):3243–52.
51. Saibi Y, Romadhon R, Nasir NM. Kepatuhan Terhadap Pengobatan Pasien Diabetes Melitus Tipe 2 di Puskesmas Jakarta Timur. J Farm Galen (Galenika J Pharmacy). 2020;6(1):94–103.
